Phase I Study of Bendamustine and Melphalan Conditioning Followed By Autologous Hematopoietic Cell Transplantation for Treatment of Multiple Myeloma and B-Cell Lymphoma in Elderly Patients

High-dose chemo and autologous hematopoietic cell transplantation (AHCT) is an effective consolidation therapy in non-Hodgkin lymphoma (NHL) and multiple myeloma (MM); however, its use in elderly patients is limited by toxicity.

Source: Biology of Blood and Marrow Transplantation - February 1, 2024 Category: Hematology Authors: Gagan Raju, Gunjan L. Shah, Stephanie M. Lobaugh, Sean M. Devlin, Grashma Vadakkel, Stephen William Eng, Andrew Lin, Amethyst Saldia, Martin Donach, Danielle Engstler, Yetunde Aremu, Oscar B. Lahoud, Paul Hamlin, Michael Scordo, Miguel-Angel Perales, Crai Tags: 214 Source Type: research